HALO logo
halo search icon
Xeris Biopharma Holdings, Inc.

US$6.23

Price Change Indicator
0.31 (5.24%)
Xeris Biopharma Holdings, Inc.
XERS · NAS

Xeris Biopharma Holdings, Inc.

Start Trading XERS for Free

US$6.23

Price Arrow0.31 (5.24%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusConsensus CheapHALO AllHALO Capital Efficiency
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Xeris Biopharma Holdings, Inc. Overview

XERS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Weak

Garp

Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Weak

About XERS

icon
icon

Telephone

1.844.445.5704

icon

Address

Suite 1300, 1375 West Fulton Street, Chicago, IL 60607

Description

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev. Gvoke is ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. Its product also includes Ogluo which is used for the treatment of severe hypoglycemia in adults, adolescents, and children aged 2 years and over with diabetes mellitus. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

XERS Price Chart

Key Stats

Market Cap

US$1.02B

PE

NaN

EV/EBITDA

39

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.3 - 10.08

Trade Value (12mth)

US$3,697,204.00

1 week

-5.13%

1 month

0.51%

YTD

-19.46%

1 year

20.33%

All time high

27.98

Key Fundamentals

EPS 3 yr Growth

-100.50%

EBITDA Margin

12.90%

Operating Cashflow

$29m

Free Cash Flow Return

11.80%

ROIC

0.20%

Interest Coverage

1.30

Quick Ratio

1.60

Other Data

Shares Outstanding (Fully Diluted)

178m

HALO Sector

Healthcare

Next Company Report Date

10-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

XERS Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
07 May 26
07 May 26

XERS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.45-0.37N/Alocklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.45-0.37N/Alocklocklock
Growth
 %locklocklocklock35.217.4100.9locklocklock
PE
 XlocklocklocklockN/AN/A2,453.1locklocklock
EV/EBITDA
 XlocklocklocklockN/AN/A39locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Xeris Biopharma Holdings, Inc. (XERS:NAS)?
Halo FAQ
The current share price of Xeris Biopharma Holdings, Inc. (XERS:NAS) is USD$6.23.
What is the 52-week high share price for Xeris Biopharma Holdings, Inc. (XERS:NAS)?
Halo FAQ
The 52-week high share price for Xeris Biopharma Holdings, Inc. (XERS:NAS) is USD$10.08.
What is the 52-week low share price for Xeris Biopharma Holdings, Inc. (XERS:NAS)?
Halo FAQ
The 52-week low share price for Xeris Biopharma Holdings, Inc. (XERS:NAS) is USD$4.30.
What is the dividend yield for Xeris Biopharma Holdings, Inc. (XERS:NAS)?
Halo FAQ
Xeris Biopharma Holdings, Inc. (XERS:NAS) does not pay a dividend.
What was Xeris Biopharma Holdings, Inc. (XERS:NAS) last dividend payment?
Halo FAQ
Xeris Biopharma Holdings, Inc. (XERS:NAS) does not pay a dividend.
What is the franking level for Xeris Biopharma Holdings, Inc. (XERS:NAS)?
Halo FAQ
Xeris Biopharma Holdings, Inc. (XERS:NAS) has a franking level of 0.00%.
In which sector is Xeris Biopharma Holdings, Inc. (XERS:NAS) classified?
Halo FAQ
Xeris Biopharma Holdings, Inc. (XERS:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial